Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Oncternal Therapeutics In...

    NASDAQ: ONCT · Real-Time Price · USD
    0.53
    -0.16 (-23.63%)
    At close: Dec 02, 2024, 9:00 PM

    Oncternal Therapeutics Revenue

    Oncternal Therapeutics reported an annual revenue of $785K, reflecting a -47.32% growth. For the quarter ending September 30, 2024, Oncternal Therapeutics generated $0 in revenue.
    Revenue (ttm)
    $785K
    Revenue Growth
    -47.32%
    Price / Sales Ratio
    40.15
    Revenue / Employee
    $29.07K
    Employees
    27
    Market Cap
    1.56M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist